SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $213,828,198 |
| Positions | 73 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| KLA CORPORATION | KLAC | COM NEW | $53,846,485 | 178,471 |
| BRISTOL-MYERS SQUIBB CO | BMY | COM | $17,127,142 | 297,243 |
| LAM RESEARCH CORPORATION | LRCX | COM NEW | $15,166,550 | 35,000 |
| SOLID BIOSCIENCES INC | SLDB | COM NEW | $6,655,298 | 666,196 |
| INTELLIA THERAPEUTICS INC | NTLA | COM | $6,520,968 | 385,400 |
| BIODESIX INC | Unresolved | COM | $6,467,429 | 286,804 |
| STOKE THERAPEUTICS INC | STOK | COM | $5,827,759 | 178,110 |
| OVINTIV INC | OVV | COM | $5,659,875 | 107,500 |
| NEKTAR THERAPEUTICS | NKTR | COM | $5,654,610 | 81,000 |
| CORCEPT THERAPEUTICS INC | CORT | COM | $4,973,540 | 57,200 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.